Rockwell Medical (RMTI) Asset Utilization Ratio (2011 - 2026)
Rockwell Medical's (RMTI) quarterly Asset Utilization Ratio came in at 1.18 in Q1 2026, down 31.59% YoY from 1.73 in Q1 2025, and down 2.22% on a QoQ basis from 1.21 in Q4 2025.
Rockwell Medical (RMTI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 16 years of Asset Utilization Ratio data on file, last reported at 1.18 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 31.59% year-over-year to 1.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.18 (down 31.59% YoY) and the FY2025 annual result came in at 1.19, down 34.67% from the prior year.
- Asset Utilization Ratio declined to 1.18 in Q1 2026, from 1.21 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.93 in Q2 2023 to a low of 1.18 in Q1 2026.
- A 5-year average of 1.57 and a median of 1.65 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 73.27% — and 2026, when it plunged 31.59%.
- Tracing RMTI's Asset Utilization Ratio over 5 years: stood at 1.44 in 2022, then gained by 10.5% to 1.6 in 2023, then increased by 9.36% to 1.75 in 2024, then plunged by 30.77% to 1.21 in 2025, then dropped by 2.22% to 1.18 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.18 (Q1 2026), 1.21 (Q4 2025), and 1.37 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn | 1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 |
| Mar 31, 2026 | 1.18 |
| Dec 31, 2025 | 1.21 |
| Sep 30, 2025 | 1.37 |
| Jun 30, 2025 | 1.65 |
| Mar 31, 2025 | 1.73 |
| Dec 31, 2024 | 1.75 |
| Sep 30, 2024 | 1.80 |
| Jun 30, 2024 | 1.82 |
| Mar 31, 2024 | 1.68 |
| Dec 31, 2023 | 1.60 |
| Sep 30, 2023 | 1.78 |
| Jun 30, 2023 | 1.93 |
| Mar 31, 2023 | 1.75 |
| Dec 31, 2022 | 1.44 |
| Sep 30, 2022 | 1.21 |
| Jun 30, 2022 | 1.37 |
| Mar 31, 2022 | 1.46 |
| Dec 31, 2021 | 1.15 |
| Sep 30, 2021 | 1.01 |